目的分析1990—2019亚洲主要国家及全球宫颈癌疾病负担,为制定宫颈癌防控策略提供科学依据。方法收集1990—2019年全球疾病负担研究(global burden of disease,GBD)数据,利用发病、死亡、伤残调整寿命年(disability-adjusted life years...目的分析1990—2019亚洲主要国家及全球宫颈癌疾病负担,为制定宫颈癌防控策略提供科学依据。方法收集1990—2019年全球疾病负担研究(global burden of disease,GBD)数据,利用发病、死亡、伤残调整寿命年(disability-adjusted life years,DALY)等指标定量评估宫颈癌的疾病负担情况,采用估计百分百变化(estimated annual percent change,EAPC)分析疾病负担时间变化趋势。结果1990—2019年,全球宫颈癌标化发病率从7.64/10万下降至6.81/10万,标化死亡率从4.46/10万降低至3.40/10万,标化DALY率从139.98/10万下降至107.20/10万,年平均降低分别为0.39%、0.96%、0.94%(EAPC<0,P<0.05)。亚洲主要国家中,中国的标化发病率从4.20/10万上升至5.53/10万,平均每年增长1.63%(EAPC>0,P>0.05)。中国宫颈癌的死亡数从2.64万增加到5.34万,相对增长1.02倍,全球及亚洲主要国家标化死亡率、标化DALY率均呈逐年下降趋势,而中国未出现下降趋势。相关分析显示,发病率与社会人口指数(socio-demographic index,SDI)无明显相关性(ρ=-0.13,P=0.11),死亡率与SDI呈负相关(ρ=-0.74,P<0.001),DALY与SDI也呈负相关(ρ=-0.77,P<0.001)。结论中国宫颈癌的标化发病率、死亡率逐年增加,疾病负担呈上升趋势,应积极采取科学有效的防控措施,降低宫颈癌疾病负担。展开更多
Background:Colorectal cancer(CRC)still ranks the top in morbidity and mortality of cancers worldwide,posing a huge threat and burden to the society.We aimed to determine the age-standardized incidence,mortality,and di...Background:Colorectal cancer(CRC)still ranks the top in morbidity and mortality of cancers worldwide,posing a huge threat and burden to the society.We aimed to determine the age-standardized incidence,mortality,and disability-adjusted life years(DALYs)of CRC and explore potential changes in the temporal trends of the CRC burden in Shanghai during 2002 to 2016.Methods:The cancer statistics and demographics were obtained from the Cancer Registry and the Statistics Bureau of Pudong New Area,respectively.Data from 2002 to 2016 were included and analyzed retrospectively.DALYs were calculated using DisMod and the age-standardized rates(ASRs)were obtained according to Segi world standard population.Joinpoint regression was used to measure the trends in CRC incidence and to estimate the annual percent change.Results:The increasing trend of CRC ASR incidence halted after 2014,coinciding with the introduction of the Shanghai CRC screening program.The ASRs of mortality and DALYs increased,at 0.42%(P<0.05)and 4.07%(P<0.001)per year,respectively,which were mainly driven by men and individuals aged above the CRC screening program target.Conclusions:The disease burden of CRC in Shanghai remains serious,especially among men,and individuals aged>74 years.The benefits of the screening program have been partially proven by the ASRs of CRC incidence,providing important insights into better and wider application of screening programs.展开更多
Background:The patterns of leukemia burden have dramatically changed in recent years.This study aimed to estimate the global trends of leukemiarelated death and disability-adjusted life-years(DALYs)from 1990 to 2017.M...Background:The patterns of leukemia burden have dramatically changed in recent years.This study aimed to estimate the global trends of leukemiarelated death and disability-adjusted life-years(DALYs)from 1990 to 2017.Methods:The data was acquired from the latest version of the Global Burden of Disease(GBD)study.Estimated annual percentage changes(EAPCs)were calculated to estimate the trend of age-standardized rate(ASR)of death and DALYs due to leukemia and its main subtypes from 1990 to 2017.Results:Globally,the numbers of death and DALYs due to leukemia were 347.58×10^(3)(95%uncertainty interval[UI]=317.26×10^(3)-364.88×10^(3))and 11975.35×10^(3)(95%UI=10749.15×10^(3)-12793.58×10^(3))in 2017,with a 31.22% and 0.03% increase in absolute numbers from 1990 to 2017,respectively.Both of their ASR showed decreasing trends from 1990 to 2017 with the EAPCs being−1.04(95%confidence interval[CI]=(−1.10-−0.99)and−1.52(95%CI=−1.59-−1.44),respectively.Globally,the most pronounced decreasing trend of death and DALYs occurred in chronic myeloid leukemia with EAPCs of−2.76(95%CI=−2.88-−2.64)and−2.84(95%CI=−2.97-−2.70),respectively,while the trend increased in acute myeloid leukemia.The death and DALYs of leukemia decreased in most areas and countries with high socio-demographic index(SDI)including Bahrain,Finland,and Australia.Conclusions:The disease burden of death and DALYs due to leukemia decreased globally,and for most regions and countries from 1990 to 2017.However,the leukemia burden is still a substantial challenge globally and required adequate and affordable medical resources to improve the survival and quality of life of leukemia patients.展开更多
Objective:To calculate the burden of road traffic accidents in Kathmandu Valley and then extrapolate this to the national level.Methods:A prospective study was performed to compute the burden of road traffic accidents...Objective:To calculate the burden of road traffic accidents in Kathmandu Valley and then extrapolate this to the national level.Methods:A prospective study was performed to compute the burden of road traffic accidents by quantification of disability-adjusted life years(DALYs)using the Global Burden of Disease Study method on the basis of 1-year data from nine hospitals in Nepal and the Department of Foren-sic Medicine and cross-checked with the Nepal Traffic Directorate.Multiple methods were applied to the extrapolated population metrics of the burden of road traffic accidents in Nepal.Results:The total number of years of life lived in disability,years of life lost,and DALYs in Nepal were 38,848±194,119,935±1464,and 158,783±1658(95% confidence interval)re-spectively.The number of years lost because of morbidity and death was similar in Kathmandu Valley.Most(75%)of the DALYs resulted from years of life lost in Nepal.Males accounted for 73% of DALYs.Almost half(44%)of the DALYs were contributed by the group aged 15-29 years.Conclusion:This study is the first to calculate the burden of road traffic accidents in Nepal using Nepal’s own data.Nepal needs to develop and enhance its own system to identify significant public health issues so as to set national priorities for prevention of road traffic accidents.展开更多
Objective:This study aimed to provide a comprehensive overview of the global burden of esophageal cancer(EC)and determine the temporal trends and factors influencing changes in the global burden.Methods:The latest inc...Objective:This study aimed to provide a comprehensive overview of the global burden of esophageal cancer(EC)and determine the temporal trends and factors influencing changes in the global burden.Methods:The latest incidence and mortality data for EC worldwide were obtained from GLOBALCAN 2022.The mortality and disability-adjusted life years(DALYs)rates for EC from 1990±2019 were sourced from the 2019 Global Burden of Diseases.Trends in EC mortality and DALYs attributable to 11 risk factors or clusters of risk were analyzed using the joinpoint regression model.The trends in age-related EC burden were assessed using a decomposition approach.Results:An estimated 511,054 new cases of EC were diagnosed in 2022 with 445,391 deaths worldwide.Approximately 75%of cases and deaths occurred in Asia.Nearly 50%of global EC deaths and DALYs were attributed to tobacco use in men in 2019,while 20%were attributed to high body mass index(BMI)in women.From 1990±2019,EC deaths and DALYs attributable to almost all risk factors had declining trends,while EC deaths and DALYs attributed to high BMI in men had upward trends.The age-related EC burden exhibited an upward trend driven by population growth and aging,which contributed to 307.4 thousand deaths and 7.2 million DALYs due to EC.Conclusions:The EC burden remains substantial worldwide.Effective tobacco and obesity control measures are critical for addressing the risk-attributable burden of EC.Population growth and aging pose challenges for EC prevention and control efforts.展开更多
BACKGROUND Colorectal cancer(CRC)plays a significant role in morbidity,mortality,and economic cost in the Belt and Road Initiative(“B and R”)countries.In addition,these countries have a substantial consumption of pr...BACKGROUND Colorectal cancer(CRC)plays a significant role in morbidity,mortality,and economic cost in the Belt and Road Initiative(“B and R”)countries.In addition,these countries have a substantial consumption of processed meat.However,the burden and trend of CRC in relation to the consumption of a diet high in processed meat(DHPM-CRC)in these“B and R”countries remain unknown.AIM To analyze the burden and trend of DHPM-CRC in the“B and R”countries from 1990 to 2019.METHODS We used the 2019 Global Burden of Disease Study to collate information regarding the burden of DHPM-CRC.Numbers and age-standardized rates(ASRs)of deaths along with the disability-adjusted life years(DALYs)were determined among the“B and R”countries in 1990 and 2019.Using joinpoint regression analysis,the average annual percent change(AAPC)was used to analyze the temporal trends of age-standardized DALYs rate(ASDALR)from 1990 to 2019 and in the final decade(2010–2019).RESULTS We found geographical differences in the burden of DHPM-CRC among“B and R”countries,with the three highest-ranking countries being the Russian Federation,China,and Ukraine in 1990,and China,the Russian Federation,and Poland in 2019.The burden of DHPM-CRC generally increased in most member countries from 1990 to 2019(all P<0.05).The absolute number of deaths and DALYs in DHPM-CRC were 3151.15[95%uncertainty interval(UI)665.74-5696.64]and 83249.31(95%UI 15628.64-151956.31)in China in 2019.However,the number of deaths(2627.57-2528.51)and DALYs(65867.39-55378.65)for DHPM-CRC in the Russian Federation has declined.The fastest increase in ASDALR for DHPM-CRC was observed in Vietnam,Southeast Asia,with an AAPC value of 3.90%[95%confidence interval(CI):3.63%-4.16%],whereas the fastest decline was observed in Kyrgyzstan,Central Asia,with an AAPC value of-2.05%(95%CI:-2.37%to-1.73%).A substantial upward trend in ASR of mortality,years lived with disability,years of life lost,and DALYs from DHPM-CRC changes in 1990-2019 and the final decade(2010-2019)for most Maritime Silk Route members in East Asia,South Asia,Southeast Asia,North Africa,and the Middle East,as well as Central Europe,while those of the most Land Silk Route members in Central Asia and Eastern Europe have decreased markedly(all P<0.05).The ASDALR for DHPM-CRC increased more in males than in females(all P<0.05).For those aged 50-74 years,the ASDALR for DHPM-CRC in 40 members exhibited an increasing trend,except for 20 members,including 7 members in Central Asia,Maldives,and 12 high or high-middle social development index(SDI)members in other regions(all P<0.05).CONCLUSION The burden of DHPM-CRC varies substantially across“B and R”countries and threatens public health.Relevant evidence-based policies and interventions tailored to the different trends of countries in SDIs or Silk Routes should be adopted to reduce the future burden of CRC in“B and R”countries via extensive collaboration.展开更多
BACKGROUND Nonalcoholic fatty liver disease(NAFLD)has become the leading cause of cirrhosis and other chronic liver diseases(COCLDs).AIM To conduct a comprehensive and comparable updated analysis of the global,regiona...BACKGROUND Nonalcoholic fatty liver disease(NAFLD)has become the leading cause of cirrhosis and other chronic liver diseases(COCLDs).AIM To conduct a comprehensive and comparable updated analysis of the global,regional,and national burden of COCLDs due to NAFLD in 204 countries and territories from 1990 and 2019 by age,sex,and sociodemographic index.METHODS Data on COCLDs due to NAFLD were collected from the Global Burden of Diseases,Injuries,and Risk Factors Study 2019.Numbers and age-standardized prevalence,death,and disability-adjusted life years(DALYs)were estimated through a systematic analysis of modelled data from the Global Burden of Diseases,Injuries,and Risk Factors Study 2019.The estimated annual percentage change was used to determine the burden trend.RESULTS In 2019,the global age-standardized prevalence rate of COCLDs due to NAFLD was 15022.90 per 100000 population[95%uncertainty interval(UI):13493.19-16764.24],which increased by 24.51%(22.63%to 26.08%)from 1990,with an estimated annual percentage change of 0.78(95%confidence interval:0.74-0.82).In the same year,however,the age-standardized death rate and age-standardized DALYs per 100000 population were 1.66(95%UI:1.20-2.17)and 43.69(95%UI:31.28-58.38),respectively.North Africa and the Middle East had the highest prevalence rates of COCLDs due to NAFLD.The death rate increased with age up to the 95+age group for both sexes.Males had higher numbers of prevalence,death rate,and DALYs than females across all age groups before the 65-69 age group.The sociodemographic index was negatively correlated with the age-standardized DALYs.CONCLUSION Globally,the age-standardized prevalence rate has increased during the past three decades.However,the agestandardized death rate and age-standardized DALYs decreased.There is geographical variation in the burden of COCLDs due to NAFLD.It is strongly recommended to improve the data quality of COCLDs due to NAFLD across all countries and regions to facilitate better monitoring of the burden of COCLDs due to NAFLD.展开更多
目的分析我国脑卒中疾病负担与危险因素的现状及趋势。方法采用2013年全球疾病负担研究(GBD 2013)数据,利用伤残调整寿命年(disability adjusted life years,DALY)反映我国不同年份、年龄、性别脑卒中疾病负担及危险因素,利用地理信息系...目的分析我国脑卒中疾病负担与危险因素的现状及趋势。方法采用2013年全球疾病负担研究(GBD 2013)数据,利用伤残调整寿命年(disability adjusted life years,DALY)反映我国不同年份、年龄、性别脑卒中疾病负担及危险因素,利用地理信息系统(GIS)制作统计地图反映不同省份的分布情况。结果随着时间推移,我国脑卒中DALY率仍有上升,主要集中于老年人群,男性DALY率远高于女性,西藏、贵州等地高于浙江、上海等东南沿海地区;高血压、水果摄入不足、高盐饮食,吸烟以及室外PM_(2.5)是前五位脑卒中危险因素。结论我国脑卒中疾病负担及危险因素在年龄、性别、地域等方面存在明显差异,急需采取针对性的预防与控制措施,减小脑卒中对个人、家庭和社会造成的负担。展开更多
目的了解新疆生产建设兵团(简称兵团)肿瘤登记地区恶性肿瘤死亡情况及疾病负担,为肿瘤防治提供依据。方法收集2010年兵团肿瘤登记地区(第七师、第八师)恶性肿瘤发病资料和死亡资料,利用死亡率(mortality)、潜在减寿年(potential years o...目的了解新疆生产建设兵团(简称兵团)肿瘤登记地区恶性肿瘤死亡情况及疾病负担,为肿瘤防治提供依据。方法收集2010年兵团肿瘤登记地区(第七师、第八师)恶性肿瘤发病资料和死亡资料,利用死亡率(mortality)、潜在减寿年(potential years of life lost,PYLL)、伤残调整生命年(disability adjusted life year,DALY)包括早死所致的健康寿命损失年(years of life lost,YLL)和残疾所致的健康寿命损失年(years lived with disability,Y L D)评价恶性肿瘤疾病负担。结果2010年肿瘤登记地区全部恶性肿瘤死亡率为113.36/10万,中标率、世标率分别为58.50/10万、79.05/10万。男性死亡率139.08/10万高于女性死亡率87.13/10万。全部肿瘤PYLL为11 603.5人年,PYLL率为10.05‰,高于兵团2008—2012年死因分析恶性肿瘤平均水平。全部肿瘤DALYs率为13.14/千人、YLDs和YLLs分别为0.83/千人和12.31/千人;男性YLLs为13.50/千人高于女性YLLs 10.88/千人。PYLL率与DALYs率随年龄增加而上升,其中PYLL和PYLL率在40岁之后达到高峰,DALYs率从40岁年龄组开始明显升高,在60~69岁年龄组达到最高,且从65岁开始男性高于女性。2010年女性DALYs/千人高于全国水平。结论兵团肿瘤登记地区肿瘤疾病负担较重,男性高于女性,中老年人肿瘤疾病负担最高,应加强肿瘤的早诊早治项目,减轻居民肿瘤疾病负担。展开更多
目的·分析重庆市糖尿病的患病率、死亡率及伤残调整寿命年(disability-adjusted life year,DALY),为开展糖尿病防治提供依据。方法·收集并整理中国死因登记报告信息系统中记录的2018年重庆市糖尿病死亡个案资料;根据《中国居...目的·分析重庆市糖尿病的患病率、死亡率及伤残调整寿命年(disability-adjusted life year,DALY),为开展糖尿病防治提供依据。方法·收集并整理中国死因登记报告信息系统中记录的2018年重庆市糖尿病死亡个案资料;根据《中国居民慢性病与营养监测工作方案(试行)》,获取2018年重庆市糖尿病患病率资料。采用SPSS 25.0软件计算重庆市糖尿病死亡率、标化死亡率、患病率、标化患病率、早死所致寿命损失年(years of life lost,YLL)率、伤残所致寿命损失年(years lived with disability,YLD)率、DALY率等指标。结果·2018年重庆市糖尿病死亡率与标化死亡率分别为16.20/10万、8.82/10万,女性的糖尿病死亡率高于男性(χ^2=3.99,P=0.045)。2018年重庆市15岁及以上居民的糖尿病患病率为17.90%,标化患病率为9.25%,男性的糖尿病患病率高于女性(χ^2=18.12,P=0.000)。2018年重庆市糖尿病YLL率、YLD率和DALY率分别为2.99‰、7.44‰与10.43‰,YLL率与YLD率占DALY率的比例分别为28.67%与71.33%。结论·重庆市糖尿病疾病负担较重,死亡率与患病率均较高,YLD率占DALY率超过70%。展开更多
目的了解辽宁省城乡居民糖尿病及其并发症的疾病负担水平和特征。方法依据辽宁省糖尿病患病和死亡资料,采用全球疾病负担研究方法,计算辽宁省城乡居民糖尿病的伤残调整生命年(DisabilityAdjusted Life Years,DALY)。结果辽宁省糖尿病疾...目的了解辽宁省城乡居民糖尿病及其并发症的疾病负担水平和特征。方法依据辽宁省糖尿病患病和死亡资料,采用全球疾病负担研究方法,计算辽宁省城乡居民糖尿病的伤残调整生命年(DisabilityAdjusted Life Years,DALY)。结果辽宁省糖尿病疾病负担(DALY)每10万人损失健康寿命299.4人.a,女性高于男性(351.1/10万:252.3/10万),城市高于农村(474.1/10万:215.8/10万),农村YLD/YLL比值(0.47)明显低于城市(0.96)。结论辽宁省糖尿病DALY是GBD2000对中国糖尿病及其并发症疾病负担估计值的2.0倍,城市居民糖尿病DALY已接近发达国家水平。展开更多
文摘目的分析1990—2019亚洲主要国家及全球宫颈癌疾病负担,为制定宫颈癌防控策略提供科学依据。方法收集1990—2019年全球疾病负担研究(global burden of disease,GBD)数据,利用发病、死亡、伤残调整寿命年(disability-adjusted life years,DALY)等指标定量评估宫颈癌的疾病负担情况,采用估计百分百变化(estimated annual percent change,EAPC)分析疾病负担时间变化趋势。结果1990—2019年,全球宫颈癌标化发病率从7.64/10万下降至6.81/10万,标化死亡率从4.46/10万降低至3.40/10万,标化DALY率从139.98/10万下降至107.20/10万,年平均降低分别为0.39%、0.96%、0.94%(EAPC<0,P<0.05)。亚洲主要国家中,中国的标化发病率从4.20/10万上升至5.53/10万,平均每年增长1.63%(EAPC>0,P>0.05)。中国宫颈癌的死亡数从2.64万增加到5.34万,相对增长1.02倍,全球及亚洲主要国家标化死亡率、标化DALY率均呈逐年下降趋势,而中国未出现下降趋势。相关分析显示,发病率与社会人口指数(socio-demographic index,SDI)无明显相关性(ρ=-0.13,P=0.11),死亡率与SDI呈负相关(ρ=-0.74,P<0.001),DALY与SDI也呈负相关(ρ=-0.77,P<0.001)。结论中国宫颈癌的标化发病率、死亡率逐年增加,疾病负担呈上升趋势,应积极采取科学有效的防控措施,降低宫颈癌疾病负担。
基金National Natural Science Foundation of China(Nos.81670546,81570544,81772519)General Project of Scientific Research of Shanghai Municipal Commission of Health and Family Planning(No.201540407)+1 种基金Reserve Academic Leaders Training Program of Pudong New Area Center for Disease Control and Prevention(No.PDCDC-HBXD2020-05)Shanghai Public Health System Construction Three-year Action Plan Outstanding Youth Talent Training Program(No.GWV-10.2-YQ43)。
文摘Background:Colorectal cancer(CRC)still ranks the top in morbidity and mortality of cancers worldwide,posing a huge threat and burden to the society.We aimed to determine the age-standardized incidence,mortality,and disability-adjusted life years(DALYs)of CRC and explore potential changes in the temporal trends of the CRC burden in Shanghai during 2002 to 2016.Methods:The cancer statistics and demographics were obtained from the Cancer Registry and the Statistics Bureau of Pudong New Area,respectively.Data from 2002 to 2016 were included and analyzed retrospectively.DALYs were calculated using DisMod and the age-standardized rates(ASRs)were obtained according to Segi world standard population.Joinpoint regression was used to measure the trends in CRC incidence and to estimate the annual percent change.Results:The increasing trend of CRC ASR incidence halted after 2014,coinciding with the introduction of the Shanghai CRC screening program.The ASRs of mortality and DALYs increased,at 0.42%(P<0.05)and 4.07%(P<0.001)per year,respectively,which were mainly driven by men and individuals aged above the CRC screening program target.Conclusions:The disease burden of CRC in Shanghai remains serious,especially among men,and individuals aged>74 years.The benefits of the screening program have been partially proven by the ASRs of CRC incidence,providing important insights into better and wider application of screening programs.
文摘Background:The patterns of leukemia burden have dramatically changed in recent years.This study aimed to estimate the global trends of leukemiarelated death and disability-adjusted life-years(DALYs)from 1990 to 2017.Methods:The data was acquired from the latest version of the Global Burden of Disease(GBD)study.Estimated annual percentage changes(EAPCs)were calculated to estimate the trend of age-standardized rate(ASR)of death and DALYs due to leukemia and its main subtypes from 1990 to 2017.Results:Globally,the numbers of death and DALYs due to leukemia were 347.58×10^(3)(95%uncertainty interval[UI]=317.26×10^(3)-364.88×10^(3))and 11975.35×10^(3)(95%UI=10749.15×10^(3)-12793.58×10^(3))in 2017,with a 31.22% and 0.03% increase in absolute numbers from 1990 to 2017,respectively.Both of their ASR showed decreasing trends from 1990 to 2017 with the EAPCs being−1.04(95%confidence interval[CI]=(−1.10-−0.99)and−1.52(95%CI=−1.59-−1.44),respectively.Globally,the most pronounced decreasing trend of death and DALYs occurred in chronic myeloid leukemia with EAPCs of−2.76(95%CI=−2.88-−2.64)and−2.84(95%CI=−2.97-−2.70),respectively,while the trend increased in acute myeloid leukemia.The death and DALYs of leukemia decreased in most areas and countries with high socio-demographic index(SDI)including Bahrain,Finland,and Australia.Conclusions:The disease burden of death and DALYs due to leukemia decreased globally,and for most regions and countries from 1990 to 2017.However,the leukemia burden is still a substantial challenge globally and required adequate and affordable medical resources to improve the survival and quality of life of leukemia patients.
文摘Objective:To calculate the burden of road traffic accidents in Kathmandu Valley and then extrapolate this to the national level.Methods:A prospective study was performed to compute the burden of road traffic accidents by quantification of disability-adjusted life years(DALYs)using the Global Burden of Disease Study method on the basis of 1-year data from nine hospitals in Nepal and the Department of Foren-sic Medicine and cross-checked with the Nepal Traffic Directorate.Multiple methods were applied to the extrapolated population metrics of the burden of road traffic accidents in Nepal.Results:The total number of years of life lived in disability,years of life lost,and DALYs in Nepal were 38,848±194,119,935±1464,and 158,783±1658(95% confidence interval)re-spectively.The number of years lost because of morbidity and death was similar in Kathmandu Valley.Most(75%)of the DALYs resulted from years of life lost in Nepal.Males accounted for 73% of DALYs.Almost half(44%)of the DALYs were contributed by the group aged 15-29 years.Conclusion:This study is the first to calculate the burden of road traffic accidents in Nepal using Nepal’s own data.Nepal needs to develop and enhance its own system to identify significant public health issues so as to set national priorities for prevention of road traffic accidents.
基金funded by the National Natural Science Foundation of China (Grant No. 82273721)Capital’s Funds for Health Improvement and Research (Grant No. 2024-1G-4023)。
文摘Objective:This study aimed to provide a comprehensive overview of the global burden of esophageal cancer(EC)and determine the temporal trends and factors influencing changes in the global burden.Methods:The latest incidence and mortality data for EC worldwide were obtained from GLOBALCAN 2022.The mortality and disability-adjusted life years(DALYs)rates for EC from 1990±2019 were sourced from the 2019 Global Burden of Diseases.Trends in EC mortality and DALYs attributable to 11 risk factors or clusters of risk were analyzed using the joinpoint regression model.The trends in age-related EC burden were assessed using a decomposition approach.Results:An estimated 511,054 new cases of EC were diagnosed in 2022 with 445,391 deaths worldwide.Approximately 75%of cases and deaths occurred in Asia.Nearly 50%of global EC deaths and DALYs were attributed to tobacco use in men in 2019,while 20%were attributed to high body mass index(BMI)in women.From 1990±2019,EC deaths and DALYs attributable to almost all risk factors had declining trends,while EC deaths and DALYs attributed to high BMI in men had upward trends.The age-related EC burden exhibited an upward trend driven by population growth and aging,which contributed to 307.4 thousand deaths and 7.2 million DALYs due to EC.Conclusions:The EC burden remains substantial worldwide.Effective tobacco and obesity control measures are critical for addressing the risk-attributable burden of EC.Population growth and aging pose challenges for EC prevention and control efforts.
基金Supported by National Natural Science Foundation of China,No.82260532,and No.32060208.
文摘BACKGROUND Colorectal cancer(CRC)plays a significant role in morbidity,mortality,and economic cost in the Belt and Road Initiative(“B and R”)countries.In addition,these countries have a substantial consumption of processed meat.However,the burden and trend of CRC in relation to the consumption of a diet high in processed meat(DHPM-CRC)in these“B and R”countries remain unknown.AIM To analyze the burden and trend of DHPM-CRC in the“B and R”countries from 1990 to 2019.METHODS We used the 2019 Global Burden of Disease Study to collate information regarding the burden of DHPM-CRC.Numbers and age-standardized rates(ASRs)of deaths along with the disability-adjusted life years(DALYs)were determined among the“B and R”countries in 1990 and 2019.Using joinpoint regression analysis,the average annual percent change(AAPC)was used to analyze the temporal trends of age-standardized DALYs rate(ASDALR)from 1990 to 2019 and in the final decade(2010–2019).RESULTS We found geographical differences in the burden of DHPM-CRC among“B and R”countries,with the three highest-ranking countries being the Russian Federation,China,and Ukraine in 1990,and China,the Russian Federation,and Poland in 2019.The burden of DHPM-CRC generally increased in most member countries from 1990 to 2019(all P<0.05).The absolute number of deaths and DALYs in DHPM-CRC were 3151.15[95%uncertainty interval(UI)665.74-5696.64]and 83249.31(95%UI 15628.64-151956.31)in China in 2019.However,the number of deaths(2627.57-2528.51)and DALYs(65867.39-55378.65)for DHPM-CRC in the Russian Federation has declined.The fastest increase in ASDALR for DHPM-CRC was observed in Vietnam,Southeast Asia,with an AAPC value of 3.90%[95%confidence interval(CI):3.63%-4.16%],whereas the fastest decline was observed in Kyrgyzstan,Central Asia,with an AAPC value of-2.05%(95%CI:-2.37%to-1.73%).A substantial upward trend in ASR of mortality,years lived with disability,years of life lost,and DALYs from DHPM-CRC changes in 1990-2019 and the final decade(2010-2019)for most Maritime Silk Route members in East Asia,South Asia,Southeast Asia,North Africa,and the Middle East,as well as Central Europe,while those of the most Land Silk Route members in Central Asia and Eastern Europe have decreased markedly(all P<0.05).The ASDALR for DHPM-CRC increased more in males than in females(all P<0.05).For those aged 50-74 years,the ASDALR for DHPM-CRC in 40 members exhibited an increasing trend,except for 20 members,including 7 members in Central Asia,Maldives,and 12 high or high-middle social development index(SDI)members in other regions(all P<0.05).CONCLUSION The burden of DHPM-CRC varies substantially across“B and R”countries and threatens public health.Relevant evidence-based policies and interventions tailored to the different trends of countries in SDIs or Silk Routes should be adopted to reduce the future burden of CRC in“B and R”countries via extensive collaboration.
基金National Key research and Development Program,No.2022YFE0131600National Natural Science Foundation of China,No.82160500+3 种基金Special Project of Central Government Guiding Local Science and Technology Development,No.ZY20198011Guangxi Science and Technology Base and Talent Project,No.GuikeAA21220002Natural Science Foundation of Guangxi,No.2022GXNSFAA035642The Liuzhou Science and Technology Plan Project,No.2021CB0101.
文摘BACKGROUND Nonalcoholic fatty liver disease(NAFLD)has become the leading cause of cirrhosis and other chronic liver diseases(COCLDs).AIM To conduct a comprehensive and comparable updated analysis of the global,regional,and national burden of COCLDs due to NAFLD in 204 countries and territories from 1990 and 2019 by age,sex,and sociodemographic index.METHODS Data on COCLDs due to NAFLD were collected from the Global Burden of Diseases,Injuries,and Risk Factors Study 2019.Numbers and age-standardized prevalence,death,and disability-adjusted life years(DALYs)were estimated through a systematic analysis of modelled data from the Global Burden of Diseases,Injuries,and Risk Factors Study 2019.The estimated annual percentage change was used to determine the burden trend.RESULTS In 2019,the global age-standardized prevalence rate of COCLDs due to NAFLD was 15022.90 per 100000 population[95%uncertainty interval(UI):13493.19-16764.24],which increased by 24.51%(22.63%to 26.08%)from 1990,with an estimated annual percentage change of 0.78(95%confidence interval:0.74-0.82).In the same year,however,the age-standardized death rate and age-standardized DALYs per 100000 population were 1.66(95%UI:1.20-2.17)and 43.69(95%UI:31.28-58.38),respectively.North Africa and the Middle East had the highest prevalence rates of COCLDs due to NAFLD.The death rate increased with age up to the 95+age group for both sexes.Males had higher numbers of prevalence,death rate,and DALYs than females across all age groups before the 65-69 age group.The sociodemographic index was negatively correlated with the age-standardized DALYs.CONCLUSION Globally,the age-standardized prevalence rate has increased during the past three decades.However,the agestandardized death rate and age-standardized DALYs decreased.There is geographical variation in the burden of COCLDs due to NAFLD.It is strongly recommended to improve the data quality of COCLDs due to NAFLD across all countries and regions to facilitate better monitoring of the burden of COCLDs due to NAFLD.
文摘目的分析我国脑卒中疾病负担与危险因素的现状及趋势。方法采用2013年全球疾病负担研究(GBD 2013)数据,利用伤残调整寿命年(disability adjusted life years,DALY)反映我国不同年份、年龄、性别脑卒中疾病负担及危险因素,利用地理信息系统(GIS)制作统计地图反映不同省份的分布情况。结果随着时间推移,我国脑卒中DALY率仍有上升,主要集中于老年人群,男性DALY率远高于女性,西藏、贵州等地高于浙江、上海等东南沿海地区;高血压、水果摄入不足、高盐饮食,吸烟以及室外PM_(2.5)是前五位脑卒中危险因素。结论我国脑卒中疾病负担及危险因素在年龄、性别、地域等方面存在明显差异,急需采取针对性的预防与控制措施,减小脑卒中对个人、家庭和社会造成的负担。
文摘目的了解新疆生产建设兵团(简称兵团)肿瘤登记地区恶性肿瘤死亡情况及疾病负担,为肿瘤防治提供依据。方法收集2010年兵团肿瘤登记地区(第七师、第八师)恶性肿瘤发病资料和死亡资料,利用死亡率(mortality)、潜在减寿年(potential years of life lost,PYLL)、伤残调整生命年(disability adjusted life year,DALY)包括早死所致的健康寿命损失年(years of life lost,YLL)和残疾所致的健康寿命损失年(years lived with disability,Y L D)评价恶性肿瘤疾病负担。结果2010年肿瘤登记地区全部恶性肿瘤死亡率为113.36/10万,中标率、世标率分别为58.50/10万、79.05/10万。男性死亡率139.08/10万高于女性死亡率87.13/10万。全部肿瘤PYLL为11 603.5人年,PYLL率为10.05‰,高于兵团2008—2012年死因分析恶性肿瘤平均水平。全部肿瘤DALYs率为13.14/千人、YLDs和YLLs分别为0.83/千人和12.31/千人;男性YLLs为13.50/千人高于女性YLLs 10.88/千人。PYLL率与DALYs率随年龄增加而上升,其中PYLL和PYLL率在40岁之后达到高峰,DALYs率从40岁年龄组开始明显升高,在60~69岁年龄组达到最高,且从65岁开始男性高于女性。2010年女性DALYs/千人高于全国水平。结论兵团肿瘤登记地区肿瘤疾病负担较重,男性高于女性,中老年人肿瘤疾病负担最高,应加强肿瘤的早诊早治项目,减轻居民肿瘤疾病负担。
文摘目的·分析重庆市糖尿病的患病率、死亡率及伤残调整寿命年(disability-adjusted life year,DALY),为开展糖尿病防治提供依据。方法·收集并整理中国死因登记报告信息系统中记录的2018年重庆市糖尿病死亡个案资料;根据《中国居民慢性病与营养监测工作方案(试行)》,获取2018年重庆市糖尿病患病率资料。采用SPSS 25.0软件计算重庆市糖尿病死亡率、标化死亡率、患病率、标化患病率、早死所致寿命损失年(years of life lost,YLL)率、伤残所致寿命损失年(years lived with disability,YLD)率、DALY率等指标。结果·2018年重庆市糖尿病死亡率与标化死亡率分别为16.20/10万、8.82/10万,女性的糖尿病死亡率高于男性(χ^2=3.99,P=0.045)。2018年重庆市15岁及以上居民的糖尿病患病率为17.90%,标化患病率为9.25%,男性的糖尿病患病率高于女性(χ^2=18.12,P=0.000)。2018年重庆市糖尿病YLL率、YLD率和DALY率分别为2.99‰、7.44‰与10.43‰,YLL率与YLD率占DALY率的比例分别为28.67%与71.33%。结论·重庆市糖尿病疾病负担较重,死亡率与患病率均较高,YLD率占DALY率超过70%。
文摘目的了解辽宁省城乡居民糖尿病及其并发症的疾病负担水平和特征。方法依据辽宁省糖尿病患病和死亡资料,采用全球疾病负担研究方法,计算辽宁省城乡居民糖尿病的伤残调整生命年(DisabilityAdjusted Life Years,DALY)。结果辽宁省糖尿病疾病负担(DALY)每10万人损失健康寿命299.4人.a,女性高于男性(351.1/10万:252.3/10万),城市高于农村(474.1/10万:215.8/10万),农村YLD/YLL比值(0.47)明显低于城市(0.96)。结论辽宁省糖尿病DALY是GBD2000对中国糖尿病及其并发症疾病负担估计值的2.0倍,城市居民糖尿病DALY已接近发达国家水平。